Tandem Diabetes Care, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Tandem Diabetes Care, Inc. (TNDM) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$9.51 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-04-26
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$9.51M, a 464.94% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$1.42M, a 131.02% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$244.00K, a 104.19% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $1.84M, a 9.34% increase year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $2.78M, a 73.37% decline from fiscal 2016.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $10.45M, a 331.56% increase from fiscal 2015.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $2.42M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$35.47M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|
| 2018-03-31 | -$9.51M 10-Q · filed 2018-04-26 | -$10.93M derived: sum of 2 quarters · filed 2018-04-26 | -$11.18M derived: sum of 3 quarters · filed 2018-04-26 | -$9.34M derived: sum of 4 quarters · filed 2018-04-26 | ||
| 2017-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$1.66M derived: sum of 2 quarters · filed 2018-03-01 | $175.00K derived: sum of 3 quarters · filed 2018-03-01 | $2.78M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | -$244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $1.59M derived: sum of 2 quarters · filed 2017-10-26 | $4.20M 10-Q · filed 2017-10-26 | $8.78M derived: sum of 4 quarters · filed 2018-04-26 | ||
| 2017-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $4.45M 10-Q · filed 2017-07-27 | $9.02M derived: sum of 3 quarters · filed 2018-04-26 | $14.85M derived: sum of 4 quarters · filed 2018-04-26 | ||
| 2017-03-31 | $2.61M 10-Q · filed 2018-04-26 | $7.18M derived: sum of 2 quarters · filed 2018-04-26 | $13.01M derived: sum of 3 quarters · filed 2018-04-26 | $14.69M derived: sum of 4 quarters · filed 2018-04-26 | ||
| 2016-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $10.40M derived: sum of 2 quarters · filed 2018-03-01 | $12.08M derived: sum of 3 quarters · filed 2018-03-01 | $10.45M 10-K · filed 2018-03-01 | ||
| 2016-09-30 | $5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $7.51M derived: sum of 2 quarters · filed 2017-10-26 | $5.87M 10-Q · filed 2017-10-26 | $14.73M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $45.00K 10-Q · filed 2017-07-27 | $8.90M derived: sum of 3 quarters · filed 2018-03-01 | $20.43M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | -$1.64M 10-Q · filed 2017-04-27 | $7.22M derived: sum of 2 quarters · filed 2018-03-01 | $18.75M derived: sum of 3 quarters · filed 2018-03-01 | $19.06M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $20.39M derived: sum of 2 quarters · filed 2018-03-01 | $20.69M derived: sum of 3 quarters · filed 2018-03-01 | $2.42M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $11.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $11.83M derived: sum of 2 quarters · filed 2016-11-01 | -$6.44M 10-Q · filed 2016-11-01 | $1.07M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2015-06-30 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$17.97M 10-Q · filed 2016-07-28 | -$10.46M derived: sum of 3 quarters · filed 2017-03-08 | -$25.61M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2015-03-31 | -$18.27M 10-Q · filed 2016-04-28 | -$10.76M derived: sum of 2 quarters · filed 2017-03-08 | -$25.91M derived: sum of 3 quarters · filed 2017-03-08 | -$23.12M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2014-12-31 | $7.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$7.64M derived: sum of 2 quarters · filed 2017-03-08 | -$4.84M derived: sum of 3 quarters · filed 2017-03-08 | -$35.47M 10-K · filed 2017-03-08 | ||
| 2014-09-30 | -$15.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$12.35M derived: sum of 2 quarters · filed 2015-10-29 | -$42.98M 10-Q · filed 2015-10-29 | -$44.58M 10-Q · filed 2014-11-06 | -$49.55M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$27.83M 10-Q · filed 2015-07-30 | -$29.43M 10-Q · filed 2014-07-31 | -$34.41M derived: sum of 3 quarters · filed 2016-02-24 | -$37.02M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-03-31 | -$30.63M 10-Q · filed 2015-04-30 | -$37.20M derived: sum of 2 quarters · filed 2016-02-24 | -$39.81M derived: sum of 3 quarters · filed 2016-02-24 | |||
| 2013-12-31 | -$6.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$9.19M derived: sum of 2 quarters · filed 2016-02-24 | -$11.11M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | -$2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$4.53M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | -$1.92M 10-Q · filed 2014-07-31 | |||||
| 2012-12-31 | -$5.53M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |